TokenPost topic

Immix Biopharma

1 TokenPost story is tagged Immix Biopharma. The newest appear first.

Latest Immix Biopharma stories

• Immix Biopharma Reports $340.9 Million in Cash, Cash Equivalents and Marketable Securities

  The company expects the balance at quarter-end to fund operations into mid-2028. Third-quarter operating expenses were $15.9 million.

  Nov 12, 2026, 6:33 PM EST · Business